• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生色团修饰的抗肿瘤咪唑并吖啶酮类化合物。合成及其对小鼠白血病的活性

Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias.

作者信息

Cholody W M, Martelli S, Konopa J

机构信息

Department of Pharmaceutical Technology and Biochemistry, Technical University of Gdansk, Poland.

出版信息

J Med Chem. 1992 Jan 24;35(2):378-82. doi: 10.1021/jm00080a026.

DOI:10.1021/jm00080a026
PMID:1732555
Abstract

The synthesis of 8-hydroxy and 8-methoxy analogues of some substituted 5-aminoimidazoacridinones (4) is described. The synthesis was carried out by a three-step sequence from the corresponding 1-chloro-4-nitro-9(10H)-acridinone precursors (1). The annulation of the imidazolo ring onto the aminoacridinone chromophore was accomplished by heating the required aminoacridinone (3) with formic acid or, in the case of 1-methyl derivatives, with N,N-dimethylacetamide. Potent cytotoxic activity against L1210 leukemia, as well as antitumor activity against P388 leukemia in mice, was demonstrated for the 8-hydroxy analogues. The corresponding 8-methoxy derivatives were not cytotoxic. However, in some cases, they showed significant in vivo antileukemic activity.

摘要

描述了一些取代的5-氨基咪唑并吖啶酮(4)的8-羟基和8-甲氧基类似物的合成。该合成由相应的1-氯-4-硝基-9(10H)-吖啶酮前体(1)通过三步序列进行。通过将所需的氨基吖啶酮(3)与甲酸加热,或者在1-甲基衍生物的情况下与N,N-二甲基乙酰胺加热,将咪唑环环合到氨基吖啶酮发色团上。8-羟基类似物对L1210白血病显示出强细胞毒性活性,以及对小鼠P388白血病的抗肿瘤活性。相应的8-甲氧基衍生物没有细胞毒性。然而,在某些情况下,它们显示出显著的体内抗白血病活性。

相似文献

1
Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias.生色团修饰的抗肿瘤咪唑并吖啶酮类化合物。合成及其对小鼠白血病的活性
J Med Chem. 1992 Jan 24;35(2):378-82. doi: 10.1021/jm00080a026.
2
Structure-activity relationship for antineoplastic imidazoacridinones: synthesis and antileukemic activity in vivo.抗肿瘤咪唑并吖啶酮类化合物的构效关系:体内合成及抗白血病活性
J Med Chem. 1996 Mar 1;39(5):1028-32. doi: 10.1021/jm950564r.
3
Potential antitumor agents. 38. 3-substituted 5-carboxamido derivatives of amsacrine.
J Med Chem. 1983 Nov;26(11):1619-25. doi: 10.1021/jm00365a013.
4
Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.潜在的抗肿瘤药物。50. N-[2-(二甲基氨基)乙基]吖啶-4-甲酰胺衍生物的体内实体瘤活性。
J Med Chem. 1987 Apr;30(4):664-9. doi: 10.1021/jm00387a014.
5
2-(aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents.
J Med Chem. 1992 Dec 25;35(26):4770-8. doi: 10.1021/jm00104a001.
6
Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives.氮杂咔唑的抗肿瘤活性。I. α-咔啉及其选定衍生物的合成与抗肿瘤特性。
Arch Immunol Ther Exp (Warsz). 1986;34(3):315-21.
7
Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.蒽吡唑类抗癌剂。针对小鼠白血病的合成及构效关系。
J Med Chem. 1987 Jan;30(1):121-31. doi: 10.1021/jm00384a021.
8
Potential antitumor agents. 42. Structure-activity relationships for acridine-substituted dimethyl phosphoramidate derivatives of 9-anilinoacridine.
J Med Chem. 1984 Aug;27(8):1053-6. doi: 10.1021/jm00374a020.
9
Benzothiopyranoindazoles, a new class of chromophore modified anthracenedione anticancer agents. Synthesis and activity against murine leukemias.苯并噻喃并吲唑类,一类新型的发色团修饰蒽二酮抗癌剂。合成及其对小鼠白血病的活性。
J Med Chem. 1988 Aug;31(8):1527-39. doi: 10.1021/jm00403a009.
10
Potential antitumor agents. 40. Orally active 4,5-disubstituted derivatives of amsacrine.
J Med Chem. 1984 Mar;27(3):363-7. doi: 10.1021/jm00369a021.

引用本文的文献

1
The interactions of Pu22 G-quadruplex, derived from promoter sequence, with antitumor acridine derivatives-An NMR/MD combined study.源自启动子序列的Pu22 G-四链体与抗肿瘤吖啶衍生物的相互作用——一项核磁共振/分子动力学联合研究
Mol Ther Nucleic Acids. 2025 Mar 13;36(2):102513. doi: 10.1016/j.omtn.2025.102513. eCollection 2025 Jun 10.
2
Metabolic Profiles of New Unsymmetrical Bisacridine Antitumor Agents in Electrochemical and Enzymatic Noncellular Systems and in Tumor Cells.新型不对称双吖啶抗肿瘤药物在电化学和酶促非细胞体系以及肿瘤细胞中的代谢谱
Pharmaceuticals (Basel). 2021 Apr 1;14(4):317. doi: 10.3390/ph14040317.
3
Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells.
抗癌咪唑并吖啶酮C-1311对雄激素依赖和雄激素非依赖前列腺癌细胞均有效。
Biomedicines. 2020 Aug 19;8(9):292. doi: 10.3390/biomedicines8090292.
4
CYP3A4 overexpression enhances apoptosis induced by anticancer agent imidazoacridinone C-1311, but does not change the metabolism of C-1311 in CHO cells.CYP3A4 过表达增强抗癌剂咪唑并吖啶酮 C-1311 诱导的细胞凋亡,但不改变 CHO 细胞中 C-1311 的代谢。
Acta Pharmacol Sin. 2014 Jan;35(1):98-112. doi: 10.1038/aps.2013.132. Epub 2013 Dec 2.
5
Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10.人尿苷二磷酸葡糖醛酸转移酶在三氮唑吖啶酮和咪唑吖啶酮抗肿瘤剂 C-1305 和 C-1311 的生物转化中的作用:UGT1A10 的高度选择性底物。
Drug Metab Dispos. 2012 Sep;40(9):1736-43. doi: 10.1124/dmd.112.045401. Epub 2012 Jun 1.
6
Physicochemical interaction of antitumor acridinone derivatives with DNA in view of QSAR studies.基于定量构效关系(QSAR)研究的抗肿瘤吖啶酮衍生物与DNA的物理化学相互作用
Med Chem Res. 2011 Nov;20(8):1385-1393. doi: 10.1007/s00044-010-9487-y. Epub 2010 Nov 17.
7
Chemotherapeutic potential of 9-phenyl acridine: biophysical studies on its binding to DNA.9-苯基吖啶的化疗潜力:与 DNA 结合的生物物理研究。
Eur Biophys J. 2010 Jul;39(8):1243-9. doi: 10.1007/s00249-010-0577-z. Epub 2010 Feb 5.
8
Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311.新型咪唑并吖啶酮抗肿瘤药物C1311的细胞摄取、细胞毒性及DNA结合研究
Br J Cancer. 1999 Sep;81(2):367-75. doi: 10.1038/sj.bjc.6690702.
9
Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation.新型咪唑并吖啶酮抗肿瘤药物C-1311在高浓度时的细胞杀伤作用受到抑制,同时伴有剂量依赖性的细胞周期扰动。
Br J Cancer. 1996 Nov;74(9):1359-68. doi: 10.1038/bjc.1996.550.